Canon Medical Systems announced that the U.S. Food & Drug Administration (FDA) has cleared its Compressed SPEEDER technology for use in the company’s Vantage Orian 1.5T MRI system.
Canon Medical Systems announced that the U.S. Food & Drug Administration (FDA) has cleared its Compressed SPEEDER technology for use in the company’s Vantage Orian 1.5T MRI system.
The technology, which is also available on the Vantage Galan 3T MRI system, can help reduce overall MRI scan times by reconstructing full resolution images from under-sampled data and avoiding unfolding error artifacts. In addition, it can help capture higher resolution images in 2D Fast Spin Echo acquisitions.
Reduced scan time not only presents an advantage for patients who find it difficult to remain still during long scans, but it also allows for additional time for disinfection of MRI systems and imaging suites between patients as practices begin to return to more normal patient volumes.
Faced with new, stringent cleaning protocols, more complex patient appointment management and other changes to workflow, the Compressed SPEEDER technology may help ease some post-pandemic growing pains for radiology departments and practices as many work to adjust to the “new normal.”
Canon’s new technology is included in an updated version of the M-Power software available for the Vantage Orian 1.5T. The software comes standard with Windows 10 and cybersecurity functionality, including continuous updates from Microsoft and whitelisting functions which allow for access only to authorized applications and processes.
“In MR imaging, shortening scan times is vastly important for both the patient and physician,” said Jonathan Furuyama, managing director, MR Business Unit, Canon Medical Systems USA, Inc., in a statement. “With the help of Compressed SPEEDER along with Windows 10 on the Vantage Orian 1.5T MR system, healthcare providers can offer a quick, comfortable and safe experience for their patients.”
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 2nd 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 2nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.